Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Two New Studies Highlight Ways To Reduce Antibiotic Use in NICUs Findings indicate that antibiotics are often given to infants with suspected sepsis, even if the condition has not been confirmed, contributing to overuse of the medications. March 14, 2025 Martha Garcia Add Your Comments Health experts are warning about serious risks associated with antibiotic overuse in neonatal intensive care units (NICU), which can increase an infant’s risk of suffering late-onset sepsis or contracting antibiotic resistant bacteria, potentially leading to severe illnesses or death. In two separate studies published last month in the medical journal Pediatrics, researchers indicate that putting in place guidelines like educational sessions, case audits and several other interventions could help reduce the overuse of antibiotics in infants by up to 80%. NICU Antibiotic Prescriptions Antibiotics are the most frequently prescribed drug in NICUs because infants born early typically face serious infections, even though data published in 2024 indicates that only about one-third of pediatric antibiotic prescriptions are given for legitimate infections. Doctors’ prescribing habits are generally held up as the primary cause for infant antibiotic overuse. For example, antibiotics are often given to infants with suspected sepsis, even when the condition has not been confirmed. For this reason, researchers are now suggesting new intervention methods are needed to help reduce unnecessary antibiotic use, which may be the best way to protect vulnerable infants from certain illnesses and death. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Reducing Antibiotic Overuse With Consensus Guidelines The first study, conducted at the Pediatrics Department at St. Christopher’s Hospital for Children in Pennsylvania, developed and implemented an antibiotic stewardship quality improvement initiative and then monitored the results. A total of 552 infants were included in the analysis. A multidisciplinary team conducted the study at a 39-bed level IV NICU facility. They used consensus guidelines with the goal of reducing antibiotic use by 20%. The guidelines included limits on antibiotic duration for common indications, educational sessions, antibiotic stop dates, and antibiotic necessity documentation in the electronic health record to standardize doctor justification for antibiotic prescription and duration. Across a four-year study period, antibiotic use decreased by 50%, with use dropping from 278 infants to 140 across the four years, according to the data. In addition, the use of antibiotics for culture-negative sepsis diagnoses fell by 64%, from 22 infants at the start to just eight by the study’s conclusion. Researchers determined that using a standardized set of guidelines focused on evidence-based outcomes can help guide doctors to prescribe antibiotics less among infant patients who simply do not need the drugs. Weekly Interventions To Reduce Overuse A separate study was conducted by researchers from the Icahn School of Medicine at Mount Sinai, New York and focused on practices for reducing antibiotic overuse. This study used antibiotic guidelines, case audits, weekly stewardship rounds and biweekly review of culture-negative sepsis cases at staff meetings. The initiative also included educational sessions, literature review and consensus discussions. Researchers found that the interventions helped decrease the use of antibiotics for any reason by 24%. They determined the program also decreased antibiotic courses for culture-negative sepsis by 68% and decreased early-onset sepsis antibiotic use from 18.3 days to 3.9 days. With regard to overall antibiotic days of therapy, use decreased from 232.5 days to 176.7 days of therapy, the researchers determined. As a result, the research team concluded that by focusing on doctor interventions antibiotics were reduced in the long-term. The most impactful intervention, according to researchers, was beginning weekly check-ins focused on proper antibiotic use to increase awareness of the importance of the program. Find Out If You Qualify for Infant Formula NEC Compensation Tags: Antibiotic Resistance, Antibiotics, Infant, Infections, NICU, Sepsis Written By: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More Baby Formula Stories Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025 Second NEC Baby Formula Bellwether Trial Will Not Move Forward July 29, 2025 Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (Posted: today) A lawsuit claims that a man’s Ozempic gastroparesis side effects have continued a year and a half after he stopped using the diabetes medication. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (10/07/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025) Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025) Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025
Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (Posted: today) A lawsuit claims that a man’s Ozempic gastroparesis side effects have continued a year and a half after he stopped using the diabetes medication. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (10/07/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)
Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)